Sitagliptin augments protective effects of GLP-1 against advanced glycation end product receptor axis in endothelial cells

Hormone and Metabolic Research

Volumn 43, Issue 10, 2011, Pages 731-734

  Ishibashi, Y ^a   Matsui, T ^a   Takeuchi, M ^b   Yamagishi, S ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKURIKU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCAGON LIKE PEPTIDE 1; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; SITAGLIPTIN;

ARTICLE; BLOOD VESSEL INJURY; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOTHERAPY; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; UMBILICAL VEIN;

GENE EXPRESSION REGULATION; GLUCAGON-LIKE PEPTIDE 1; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NITRIC OXIDE SYNTHASE TYPE III; PROTECTIVE AGENTS; PYRAZINES; REACTIVE OXYGEN SPECIES; RECEPTORS, IMMUNOLOGIC; SERUM ALBUMIN, BOVINE; TRIAZOLES;

EID: 80052963329     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0031-1284383     Document Type: Article

References (16)

1. Yamagishi S, Nakamura K, Matsui T. Pharmacol Res: 2009; 60 174 178
2. Yamagishi S, Imaizumi T. Curr Pharm Des: 2005; 11 2279 2299
3. Yan SF, Ramasamy R, Schmidt AM. Circ Res: 2010; 106 842 853
4. Bierhaus A, Nawroth PP. Diabetologia: 2009; 52 2251 2263
5. Dhillon S. Drugs: 2010; 70 489 512
6. Yamagishi S, Nakamura K, Matsui T, Inagaki Y, Takenaka K, Jinnouchi Y, Yoshida Y, Matsuura T, Narama I, Motomiya Y, Takeuchi M, Inoue H, Yoshimura A, Bucala R, Imaizumi T. J Biol Chem: 2006; 281 20213 20220
7. Yoshida T, Yamagishi S, Nakamura K, Matsui T, Imaizumi T, Takeuchi M, Koga H, Ueno T, Sata M. Diabetologia: 2006; 49 3094 3099
8. Kasichayanula S, Liu X, Shyu WC, Zhang W, Pfister M, Griffen SC, Li T, LaCreta FP, Boulton DW. Diabetes Obes Metab: 2011; 13 47 54
9. Herman GA, Bergman A, Liu F, Stevens C, Wang AQ, Zeng W, Chen L, Snyder K, Hilliard D, Tanen M, Tanaka W, Meehan AG, Lasseter K, Dilzer S, Blum R, Wagner JA. J Clin Pharmacol: 2006; 46 876 886
10. Takasawa W, Ohnuma K, Hatano R, Endo Y, Dang NH, Morimoto C. Biophys Res Commun: 2010; 391 1405 1408
11. Ishibashi Y, Matsui T, Takeuchi M, Yamagishi S. Biochem Biophys Res Commun: 2010; 391 1405 1408
12. Herman GA, Bergman A, Stevens C, Kotey P, Yi B, Zhao P, Dietrich B, Golor G, Schrodter A, Keymeulen B, Lasseter KC, Kipnes MS, Snyder K, Hilliard D, Tanen M, Cilissen C, De Smet M, de Lepeleire I, Van Dyck K, Wang AQ, Zeng W, Davies MJ, Tanaka W, Holst JJ, Deacon CF, Gottesdiener KM, Wagner JA. J Clin Endocrinol Metab: 2006; 91 4612 4619
13. Marfella R, Barbieri M, Grella R, Rizzo MR, Nicoletti GF, Paolisso G. J Diabetes Complications: 2010; 24 79 83
14. Yamagishi S, Ueda S, Matsui T, Nakamura K, Imaizumi T, Takeuchi M, Okuda S. Protein Pept Lett: 2007; 14 832 835
15. Takeuchi M, Makita Z, Yanagisawa K, Kameda K, Koike T. Mol Med: 1999; 5 393 405
16. Takeuchi M, Yanase Y, Matsuura N, Yamagishi S, Kameda Y, Bucala R, Makita Z. Mol Med: 2001; 7 783 791